FDA Accepts ANI’s Refiled Cortophin Gel
For Indications Including Multiple Sclerosis, Rheumatoid Arthritis And Nephrotic Syndrome
• By Akriti Seth
After refusing the application last year, the FDA has accepted ANI’s refiled Cortophin Gel sNDA • Source: Alamy 
